Cargando…
Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
BACKGROUND: Blood eosinophil counts have been documented as a good biomarker for patients with chronic obstructive pulmonary disease (COPD) using inhaled corticosteroid (ICS) therapy. However, the effectiveness and safety of prescribing high or medium dose of ICS for patients with different eosinoph...
Autores principales: | Cheng, Shih-Lung, Lin, Ching-Hsiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036601/ https://www.ncbi.nlm.nih.gov/pubmed/27703344 http://dx.doi.org/10.2147/COPD.S115132 |
Ejemplares similares
-
Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
por: Cheng, Shih-Lung
Publicado: (2018) -
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016) -
Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017) -
Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)